Computational model enhances protein kinase target prediction for therapies
Protein kinase research presents an opportunity to explore molecular targets in the body to treat diseases like cancer and ...
American Association of Individual Investors8h
Why Terns Pharmaceuticals, Inc.’s (TERN) Stock Is Up 14.97%
Terns Pharmaceuticals, Inc.’s TERN share price has surged by 14.97%, which has investors questioning if this is right time to ...
This Is What Whales Are Betting On SpringWorks Therapeutics
Financial giants have made a conspicuous bearish move on SpringWorks Therapeutics. Our analysis of options history for ...
Studying structure of G protein-coupled receptor kinases could improve an array of drugs
Each cell in your body relies on precise communication with other cells to function properly. At the center of this process ...
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and ...
Alumis Reports Year End 2024 Financial Results and Highlights Recent Achievements
Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to ...
Janus Kinase (JAK) Inhibitor Pipeline Market Insights Report 2025: Comprehensive Review of 50+ Companies and Respective 55+ Drugs
The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.The "Janus Kinase (JAK) Inhibitor- Pipeline Insight, 2025" report ...
technologynetworks1mon
Next-Generation Kinase Inhibitors: Overcoming Resistance and Enhancing Clinical Outcomes
Protein kinase inhibitors have revolutionized cancer treatment by targeting specific kinases involved in tumor growth and survival. As of 2024, over 80 small-molecule protein kinase inhibitors have ...
Nature2mon
Recognizing and exploiting differences between RNAi and small-molecule inhibitors
Whereas small-molecule inhibition and the moderate overexpression of catalytic mutants simply reduces Aurora B kinase activity in the cell, RNAi disrupts the CPC, leading to a more global ...